P. Järvinen

发表

Occurrence of ankylosing spondylitis in a nationwide series of twins.

P. Järvinen, 1995, Arthritis and rheumatism.

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission

H. B. Hammer, L. Terslev, M. Leirisalo-Repo, 2021, Rheumatology advances in practice.

Concise report Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission in Practice

H. B. Hammer, L. Terslev, M. Leirisalo-Repo, 2021 .

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.

R. Moots, A. Loft, A. Ostor, 2012, Rheumatology.

Co‐twin control study on cerebral manifestations of systemic lupus erythematosus

L. Ketonen, R. Sepponen, E. Kinnunen, 1993, Acta neurologica Scandinavica.

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

J. Reveille, E. Lespessailles, P. Rahman, 2019, Arthritis & rheumatology.

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Tae-Hwan Kim, S. Visvanathan, M. Østergaard, 2018, Annals of the rheumatic diseases.

Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis

L. Terslev, M. Leirisalo-Repo, B. Agular, 2021, Scandinavian journal of rheumatology.

Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.

I. Olivieri, H. Kupper, M. Kron, 2008, Rheumatology.

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

P. Hannonen, T. Möttönen, M. Hakola, 1999, The Lancet.

Twin studies in rheumatic diseases.

K. Aho, P. Järvinen, 1994, Seminars in arthritis and rheumatism.

Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis.

P. Hannonen, T. Möttönen, H. Kautiainen, 2007, Clinical and experimental rheumatology.

Serum IL-1β levels are associated with the presence of erosions in recent onset rheumatoid arthritis

P. Hannonen, T. Möttönen, H. Kautiainen, 2006 .

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

P. Hannonen, T. Möttönen, H. Kautiainen, 2005, Arthritis and rheumatism.

Clustering of symptoms associated with fibromyalgia in a Finnish Twin Cohort

E. Kalso, J. Kaprio, M. Koskenvuo, 2009, European journal of pain.

Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features

J. Kaprio, M. Koskenvuo, K. Aho, 1992, Journal of internal medicine.

Intraarticular osmic acid in postinfectious arthritis persisting after treated bacterial arthritis.

M. Nissilä, R. von Essen, P. Järvinen, 1990, The Journal of rheumatology.

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN‐RACo trial

P. Hannonen, T. Möttönen, H. Kautiainen, 2007, Scandinavian journal of rheumatology.

Fibromyalgia in a pair of identical twins.

K. Aho, P. Järvinen, 1990, Clinical and experimental rheumatology.